Poradosu Enrique 4
4 · Nuvectis Pharma, Inc. · Filed May 13, 2024
Insider Transaction Report
Form 4
Poradosu Enrique
Chief Science & Business Off
Transactions
- Purchase
Common Stock
2024-05-10$6.29/sh+500$3,145→ 1,504,319 total
Footnotes (1)
- [F1]Includes 353,399 shares of restricted stock.